NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









INTENT Biologics

INTENT Biologics

Private
Rochester, MinnesotaHealthcare & Life Scienceshttps://intent.bio/

Last Round

VC Round

Sep 1, 2025

Company Overview

INTENT Biologics is a biotechnology company that develops exosome-based therapeutics for advanced wound care and immune-mediated conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

exosome therapeuticsregenerative medicinewound careexosome therapyadvanced wound carebiologicstissue regenerationbiotechimmune modulationlyophilized therapeuticsclinical-stage biotechchronic wound managementcell-free therapydiabetic foot ulcersbiomanufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

INTENT Biologics Comparables

Compare INTENT Biologics with similar companies based on industry and business-model similarity.

INTENT Biologics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aegle Therapeutics Corp
79%
BREXOGEN Inc.
69%
Direct Biologics
68%
View all Comparables

INTENT Biologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 1, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Suneet Varma

Chief Executive Officer

Executive Team

INTENT Biologics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

INTENT Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about INTENT Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRochester, Minnesota
Employee Range1
Year Founded2025
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.